Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Topical estradiol allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to estradiol |
Causative agent (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oral estradiol allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol implant allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol enanthate (substance) |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Albumin bound estradiol (substance) |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bioavailable estradiol (substance) |
Is a |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Albumin bound estradiol (substance) |
Is modification of (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol cypionate |
Is modification of (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol acetate (substance) |
Is modification of (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol hemihydrate (substance) |
Is modification of (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol enanthate (substance) |
Is modification of (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Free estradiol |
Is modification of (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bioavailable estradiol (substance) |
Is modification of (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol benzoate |
Is modification of (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol valerate |
Is modification of (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol (substance) |
Is modification of (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 4 mg oral tablet |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
Has precise active ingredient |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.5 mg oral tablet |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1 mg oral tablet |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
Has precise active ingredient |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing drospirenone and estradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing estradiol in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 3.125 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 3.125 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.042 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.042 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.563 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.563 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
False |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol- and medroxyprogesterone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing estradiol and levonorgestrel in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol- and medroxyprogesterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol- and norethisterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing estradiol and norethisterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only drospirenone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol and levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol and medroxyprogesterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol and norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only estradiol and norgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dydrogesterone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol and levonorgestrel only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only estradiol and medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only estradiol and norethisterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only estradiol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol and norethisterone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Drospirenone and estradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 4.167 microgram/hour prolonged-release vaginal ring |
Has basis of strength substance (attribute) |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 4.167 microgram/hour prolonged-release vaginal ring |
Has precise active ingredient |
True |
Estradiol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |